PREDICTORS OF RESPONSE TO RUXOLITINIB THERAPY IN PATIENTS WITH MYELOFIBROSIS
Presentation Type: Oral. Abstract Category: Adult Hematology Abstract Categories -> Myeloproliferative Neoplasms. Objective: Since the introduction of targeted therapy for myelofibrosis and the incorporation of ruxolitinib into clinical practice, overall survival rates have significantly improved...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-07-01
|
| Series: | Hematology, Transfusion and Cell Therapy |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2531137925001452 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|